Literature DB >> 1795174

Immunocytochemical analysis of dystrophin in congenital muscular dystrophy.

E Arikawa1, T Ishihara, I Nonaka, H Sugita, K Arahata.   

Abstract

Using immunocytochemical methods, we examined the intensity and distribution of dystrophin and spectrin immunostaining of skeletal muscles from 51 congenital muscular dystrophy (CMD) patients including 36 Fukuyama congenital muscular dystrophy (FCMD) and 15 non-FCMD (other CMD). 17 age-matched spinal muscular atrophy (SMA) and 5 Duchenne muscular dystrophy (DMD) patient biopsies were studied as controls. All 15 non-FCMD and SMA patients showed normal localization of dystrophin at the surface membrane of each muscle fiber which was undetectable in DMD. In contrast, 34 of 36 FCMD patients exhibited an unusual immunostaining pattern with occasional (17-43%; mean = 28) negative or abnormally immunoreacted (partially deficient, fluffy or intense) fibers for dystrophin. Dystrophin was absent in 2 of 36 patients having a clinical diagnosis of FCMD, and intragenic deletion of the DMD gene was detected in one. Spectrin, a membrane cytoskeletal protein related to dystrophin, also showed an increased number of abnormally immunostained fibers in FCMD (25%), but not so high in age-matched DMD (9%) or SMA patient muscle (0%). Thus, our results suggested the presence of intrinsic factor(s) that produce abnormality of the plasma membrane of FCMD muscle.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1795174     DOI: 10.1016/0022-510x(91)90122-n

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

1.  Dystrophin-related protein in skeletal muscles in neuromuscular disorders: immunohistochemical study.

Authors:  M Takemitsu; I Nonaka; H Sugita
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

2.  Congenital muscular dystrophy. A study on the variability of morphological changes and dystrophin distribution in muscle biopsies.

Authors:  Q H Leyten; H J ter Laak; F J Gabreëls; W O Renier; K Renkawek; R C Sengers
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

3.  Possible influences on the expression of X chromosome-linked dystrophin abnormalities by heterozygosity for autosomal recessive Fukuyama congenital muscular dystrophy.

Authors:  A H Beggs; P E Neumann; K Arahata; E Arikawa; I Nonaka; M S Anderson; L M Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

4.  Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 3. Differential diagnosis and prognosis.

Authors:  L V Nicholson; M A Johnson; K M Bushby; D Gardner-Medwin; A Curtis; I B Ginjaar; J T den Dunnen; J L Welch; T J Butler; E Bakker
Journal:  J Med Genet       Date:  1993-09       Impact factor: 6.318

5.  Zebrafish Fukutin family proteins link the unfolded protein response with dystroglycanopathies.

Authors:  Yung-Yao Lin; Richard J White; Silvia Torelli; Sebahattin Cirak; Francesco Muntoni; Derek L Stemple
Journal:  Hum Mol Genet       Date:  2011-02-11       Impact factor: 6.150

6.  Severe dystrophinopathy in a patient with congenital hypotonia.

Authors:  G Cordone; M Bado; G Morreale; M Pedemonte; C Minetti
Journal:  Childs Nerv Syst       Date:  1996-08       Impact factor: 1.475

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.